An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

已完结 10 由 OM 发布于 2025/12/16 16:33:26

DOI:10.1016/j.cell.2025.05.038
作者：Xiaobing Wang, Yi Zhang, Yi Jin, Lie Dai, Yanan Yue, Jiapan Hu, Xin Liu, Kun Pang, Songying Ye, Yue Chen, Wenjing Ye, Xiaofei Shi, Xin Ma, Lehang Guo, Yanfang Liu, Na Ta, Xiaofang Zhu, Li Lin, Jiazhen
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：This study reports the first-in-human application of iPSC-derived CD19/BCMA dual-targeting chimeric antigen receptor-natural killer (CAR-NK) cells (QN-139b) in a patient with severe, diffuse

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierEffects of ultrasound–assisted freezing on the quality of large yellow croaker (Pseudosciaena crocea) subjected to multiple freeze–thaw cycles